Asia Pacific Urinalysis Market (2024-2029)
The Asia Pacific Urinalysis Market was valued at $1106.4 Million in 2024 and projected to reach to $1934.3 Million by 2029, representing a compound annual growth rate of 11.8%. The Asia Pacific urinalysis market is positioned for exceptional growth, expanding from $1,106.4 million in 2024 to $1,934.3 million by 2029.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Asia Pacific Urinalysis Market Trends and Insights
- Asia Pacific's 11.8% compound annual growth rate significantly outpaces global trends, driven by rising healthcare investments, increasing prevalence of chronic diseases, and expanding diagnostic infrastructure across the region.
- The market benefits from growing awareness of preventive healthcare and improving access to laboratory services in emerging economies throughout Asia Pacific. Asia Pacific's urinalysis market expansion is supported by technological advancements in diagnostic testing and rising demand for point-of-care testing solutions.
- Between 2024 and 2029, Asia Pacific is expected to capture substantial market share as countries invest in modernizing their healthcare systems and laboratory capabilities.
- The region's large population base, coupled with improving healthcare expenditure, positions Asia Pacific as a critical growth engine for the global urinalysis market..
Key Market Statistics
- CAGR (2024-2029) 11.8% CAGR
- Market Size, 2024 ~USD 1106.4 Million
- Forecast, 2029 ~USD 1934.3 Million
- Geography Asia Pacific
Asia Pacific Urinalysis Market Overview
Fastest Growing Regional Market :
Asia Pacific's urinalysis market grows at 11.8% CAGR, significantly outpacing the global rate of 9.6%, driven by rapid healthcare modernization and diagnostic adoption across emerging economies.
China Dominates Regional Market :
China leads Asia Pacific with $663.3 million in market size, representing over 60% of the region's urinalysis market and serving as the primary growth engine for diagnostic expansion.
Rising Chronic Disease Burden :
Increasing prevalence of diabetes, kidney disease, and urinary tract infections across Asia Pacific populations is driving demand for routine urinalysis testing and preventive healthcare screening.
Expanding Diagnostic Infrastructure :
Growing investments in laboratory automation, point-of-care testing facilities, and healthcare digitalization in Asia Pacific countries are accelerating urinalysis market penetration and accessibility.
Asia Pacific Urinalysis Market Dynamics
- This 11.8% CAGR reflects the region's strengthening healthcare systems, rising middle-class populations seeking preventive care, and government initiatives to improve diagnostic capabilities.
- China and Japan remain market leaders, while emerging economies like India present significant untapped opportunities. Key growth catalysts include increasing healthcare spending, rising awareness of chronic disease screening, and technological advancements in automated urinalysis systems.
- The region's young, growing population combined with improving healthcare access in developing nations creates sustained demand for diagnostic testing.
- Strategic partnerships between local healthcare providers and international diagnostic manufacturers will further accelerate market expansion throughout the forecast period..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Asia Pacific urinalysis market valued at $1,106.4 million in 2024, expanding at 11.8% CAGR through 2029
- Asia Pacific growth rate of 11.8% significantly exceeds the global CAGR of 9.6%, reflecting regional market strength
- Asia Pacific market projected to reach $1,934.3 million by 2029, driven by healthcare infrastructure development and chronic disease prevalence
- Asia Pacific's large population and rising healthcare investments position the region as a key growth driver for global urinalysis demand
Urinalysis Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | HOSPITALS & CLINICS (End User) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 9.6% from 2024 to 2029 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 4.3 (2024) |
| Revenue Forecast (Billions) | ~USD 6.8 (2029) |
| Segments Covered | Product, Type, Test Type, Application, End User |
Asia Pacific Urinalysis Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Automated Urine Analyzers
- Biochemical Urine Analyzers
- Brazil
- Diabetes
- Dipsticks
- Disposables
- Flow Cytometry Analyzers
- Integrated Urine Analyzers
- Kidney Diseases
- Laboratory Tests
- Liver Diseases
- Mexico
- Microscopy Analyzers
- Other Disease Screening Applications
- Poc Tests
- Point-Of-Care Urine Analyzers
- Pregnancy & Fertility Kits
- Reagents
- Rest Of Latam
- Sediment Urine Analyzers
- Semi-Automated Urine Analyzers
- Urinary Tract Infections
By Test Type
- Biochemical Tests
- Pregnancy & Fertility Tests
- Sediment Urinalysis
By Application
- Disease Screening
- Pregnancy & Fertility Testing
By End User
- Diagnostic Laboratories
- Home Care Settings
- Hospitals & Clinics
- Research Laboratories & Institutes
Target Audience
- Diagnostic Equipment Manufacturers : Manufacturers need Asia Pacific market data to expand product portfolios, identify high-growth country markets, and develop region-specific urinalysis testing solutions aligned with local healthcare standards.
- Healthcare System Investors : Investors require detailed market forecasts and growth drivers to evaluate investment opportunities in Asia Pacific diagnostic infrastructure, laboratory networks, and healthcare technology companies.
- Clinical Laboratory Operators : Laboratory operators need market insights to plan capacity expansion, adopt new testing technologies, and understand competitive dynamics across Asia Pacific healthcare markets.
- Healthcare Policy Makers : Government and regulatory bodies require market intelligence to develop healthcare policies, allocate diagnostic resources, and establish standards for urinalysis testing across Asia Pacific regions.
- Medical Device Distributors : Distributors need regional market data to identify high-demand territories, forecast sales potential, and develop go-to-market strategies for urinalysis products in Asia Pacific.
Countries within Asia Pacific - compare and drill down
| Country | 2025 size (native) |
|---|---|
| China | USD 663.3 Million |
| Japan | USD 345.3 Million |
| India | USD 201.3 Million |
| Australia | USD 64.9 Million |
| South Korea | USD 55.8 Million |
| Rest Of Asia Pacific | USD 127.7 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Dominance Insights : Understand China's $663.3M market leadership and identify growth opportunities across Japan, India, and emerging Asia Pacific economies with detailed country-level analysis.
- Outpacing Global Growth Trends : Capitalize on Asia Pacific's 11.8% CAGR—2.2 percentage points above global average—to position products and services in the fastest-growing diagnostic market region.
- Healthcare Infrastructure Expansion : Access strategic intelligence on diagnostic facility expansion, automation adoption, and point-of-care testing deployment across Asia Pacific healthcare systems.
- Emerging Market Entry Strategy : Develop market entry and localization strategies for high-growth emerging economies in Asia Pacific with detailed demand forecasts and competitive landscape analysis.
- Investment and Partnership Opportunities : Identify key investment targets and partnership opportunities with regional healthcare providers, diagnostic manufacturers, and technology integrators across Asia Pacific.
Frequently asked questions
What is the current size of the Asia Pacific urinalysis market?
The Asia Pacific urinalysis market was valued at $1,106.4 million in 2024 and is projected to grow to $1,934.3 million by 2029.
What is the growth rate for urinalysis in Asia Pacific?
Asia Pacific's urinalysis market is growing at a compound annual growth rate (CAGR) of 11.8% from 2024 to 2029.
How does Asia Pacific's growth compare to global urinalysis market growth?
Asia Pacific's 11.8% CAGR outpaces the global urinalysis market CAGR of 9.6%, indicating stronger regional growth momentum.
What factors are driving urinalysis market growth in Asia Pacific?
Key drivers include rising healthcare investments, increasing chronic disease prevalence, expanding diagnostic infrastructure, and growing demand for point-of-care testing solutions across Asia Pacific.
Which countries in Asia Pacific are leading the urinalysis market expansion?
Emerging economies throughout Asia Pacific with improving healthcare systems and rising healthcare expenditure are driving significant market expansion in the region.
RESEARCH METHODOLOGY
The objective of this study is to analyze the key market dynamics, including drivers, opportunities, constraints, challenges, and strategies employed by key players. Developments within companies, such as acquisitions, product launches, expansions, agreements, and partnerships, will be tracked to assess the competitive landscape of the urinalysis market. This analysis will evaluate market players across various parameters within the broader categories of business and product strategy.
To estimate the market size, both top-down and bottom-up approaches were used. The market breakdown and data triangulation were used to determine the sizes of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources, including annual reports, press releases and investor presentations from companies, white papers, certified publications, articles by recognized authors, gold- and silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva), were consulted to identify and collect information for this study.
Primary Research
In the primary research process, interviews with sources from both the supply and demand sides were conducted to gather qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with key industry participants, subject-matter experts, C-level executives at key market players, and industry consultants to obtain and verify critical qualitative and quantitative information and to assess prospects.
Note 1: Other designations include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
|
COMPANY NAME |
DESIGNATION |
|
Sysmex Corporation |
Sales Manager |
|
Thermo Fisher Scientific, Inc. |
Sales Executive |
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the urinalysis market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research.
- The revenue generated by leading players operating in the urinalysis market was determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After determining the overall market size using the process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.
Market Definition
Urinalysis is a procedure used to assess the appearance, concentration, and content of urine. It detects and helps manage various disorders, such as urinary tract infections, kidney diseases, diabetes, and other metabolic disorders. The primary urinalysis tests include biochemical and sediment analysis. In this report, we have also discussed pregnancy and fertility tests for urine analysis.
Key Stakeholders
- Manufacturers and Distributors of Urinalysis Products
- Hospitals & Clinics
- Diagnostic Laboratories
- Research Laboratories & Institutes
- Research & Development (R&D) Companies
- Government Associations
- Venture Capitalists and Investors
Report Objectives
- To define, segment, and forecast the urinalysis market by product, test type, application, technology, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
- To study the impact of AI on the market, along with the macroeconomic outlook for each region
Available customizations:
MarketsandMarkets offers the following customizations for this market report.
Country Information
- Additional country-level analysis of the urinalysis market
Company profiles
- Additional five company profiles of players operating in the urinalysis market.
Product Analysis
- Product matrix, which provides a detailed comparison of the product portfolio of each company in the urinalysis market
Get the Full Urinalysis Market Report
Full forecast, segment splits, and company analysis for all Urinalysis Market.
- Mexico Urinalysis Market
- Rest Of Europe Urinalysis Market
- Rest Of Asia Pacific Urinalysis Market
- Rest Of Latin America Urinalysis Market
- Canada Urinalysis Market
- US Urinalysis Market
- Germany Urinalysis Market
- UK Urinalysis Market
- France Urinalysis Market
- Italy Urinalysis Market
- Spain Urinalysis Market
- Russia Urinalysis Market
- China Urinalysis Market
- Japan Urinalysis Market
- India Urinalysis Market
- Australia Urinalysis Market
- South Korea Urinalysis Market
- Brazil Urinalysis Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
